Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD

Completed · Not applicable

Conditions studied: Age-Related Macular Degeneration, Choroidal Neovascularization, Genetic Counseling

In brief

The goals of this study are: To assess the impact of genetic testing based on how it alters behaviors, to assess the utility of serum biomarker measurement in combination with genetic testing, to assess the utility of genetic counseling in personal analysis of risk for age-related macular degeneration (AMD), and to assess the impact of presymptomatic genetic testing for choroidal neovascularization (CNV).

Key facts

Study ID

NCT03024424

Run by

University of Utah

People needed

16

Starts

2016-03-01

Expected to finish

2017-08-10

Last updated by the study team

2023-05-06

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Caucasian (this particular genetic test is only validated in Caucasians) Participants can have a positive family history of AMD but this is not necessary.

You may not qualify if…

• Individuals with a personal history of AMD are not eligible. Non-caucasian individuals are not eligible. Employees of the Moran Eye Center are not eligible.
• Individuals with a personal history of previous AMD genetic risk testing are not eligible.
• Individuals with a major psychiatric disorder

Where it is running

• University of Utah John A. Moran Eye Center — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.